Pityriasis Rotunda

Clinical guidelines for managing acquired circular scaling dermatoses, evaluating underlying malignancy and systemic associations, and reviewing topical keratolytics.

⏱️ 4 min read

Table of Contents

🧠 Standard of Care & Symptoms

Pityriasis Rotunda is an extremely rare, acquired cutaneous disorder characterized by large, perfectly circular, scaling lesions that serve as a cutaneous marker for underlying systemic pathology.

πŸ”¬ Diagnostics & Systemic Screenings

Because pityriasis rotunda is a cutaneous manifestation of internal disease, clinical confirmation must trigger a comprehensive systemic evaluation.

Histopathology Details & Nutritional/Malabsorptive Mechanisms

The circular plaques of pityriasis rotunda are cellular signatures of metabolic or cachectic systemic stress:

πŸ’Š Underlyling Disease Care & Topical Keratolytics

Therapy focuses primarily on diagnosing and treating the underlying systemic infection or tumor. The skin patches typically resolve completely once the primary condition is treated.

Primary Systemic Treatment

Topical Symptomatic Support

πŸ”¬ Active Clinical Trials

Clinical trials are currently evaluating screening algorithms for paraneoplastic syndromes, the prevalence of underlying active tuberculosis in pityriasis rotunda cohorts, and efficacy of topical retinoid formulations.

NCT06922550: Paraneoplastic Screening Registry in Circular Scaling Patches

A multi-center observational registry tracking the rates of internal malignancy discovery following a standardized diagnosis of pityriasis rotunda.

Key Inclusion: Age ≥ 18, presenting with one or more perfectly circular/oval hyperpigmented scaling patches ≥ 5 cm in diameter, pathologically confirmed pityriasis rotunda on skin biopsy, and willing to undergo screening workup.
NCT07050330: Systemic Tuberculosis screening Yield

Evaluating the diagnostic yield of systemic tuberculosis screening in patients presenting with circular scaling patches.

Key Inclusion: Age ≥ 12, biopsy-confirmed pityriasis rotunda, no history of treated tuberculosis, and scheduled for systemic screening including QuantiFERON gold assay and chest radiograph.
NCT07119233: Topical Tazarotene Gel vs. Salicylic Acid Ointment

Testing the efficacy of topical tazarotene gel versus salicylic acid ointment in idiopathic, benign pityriasis rotunda.

Key Inclusion: Age 18 to 70, diagnosed with idiopathic pityriasis rotunda (defined as no associated malignancies or chronic systemic infections on full workup), and having bilateral/symmetric dry scaling plaques.
Important: Browse actively recruiting clinical trials in our Clinical Trials Catalogue to find a local study.

πŸ—ΊοΈ Next Steps After Diagnosis

If you have recently been diagnosed with Pityriasis Rotunda, implement these medical care steps:

  1. Confirm via Skin Biopsy: Differentiate the circular lesions from tinea corporis or acquired ichthyosis via punch biopsy.
  2. Schedule a Comprehensive Physical Exam: Consult an internist or primary care physician immediately for a thorough systemic evaluation.
  3. Undergo Tuberculosis and Cancer Screening: Complete blood tests, liver function panels, chest imaging, and abdominal ultrasounds to check for underlying chronic infections or tumors.
  4. Apply Topical Hydrating Agents: Apply urea-based or salicylic acid emollients twice daily to manage the scaling while systemic tests are completed.

❓ Patient FAQ

Q: Why is my doctor ordering so many tests for a simple skin spot?
A: Pityriasis rotunda is highly unique because the skin lesions themselves are completely harmless, but they are very frequently a "red flag" or sign of an underlying internal disease. Up to 30% of patients with this rash have an underlying chronic infection like tuberculosis, or an internal tumor. Finding and treating that underlying disease is the most important step for your health, and it will also cause the skin spots to clear up.

Q: Are these circular patches contagious? Can my partner catch them?
A: No. Pityriasis rotunda is not contagious. The patches are not caused by an active skin infection (such as ringworm) and cannot be passed to anyone else. It is a localized reaction of the skin tissue related to systemic health factors, nutrition, or immune changes.

Get the Free 2026 Clinical AI Directory

Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.

Request Directory via Email